Real-World Management of AEs with ALK Inhibitors

Opinion
Video

Medical experts compare the adverse event profile of lorlatinib to other ALK inhibitors like alectinib and brigatinib, discussing unique challenges and benefits observed in clinical practice.

Video content above is prompted by the following:

  • Based on your experience, how does the adverse event profile of lorlatinib compare to those of other ALK inhibitors like alectinib or brigatinib?
  • Are there any unique challenges or benefits you've observed?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with red hair and glasses wearing a black blouse and cross necklace in front of a dark blue background
Photo of a man wearing a suit with a blue tie in front of a dark blue background
4 experts in this video
4 experts in this video
Photo of a man wearing glasses and a suit in front of a blue background
Related Content